For antibody manufacturers using hybridoma cell lines 

Enhance yield and cost-effectiveness in hybridoma cell growth and antibody production 

As a company that demands antibody manufacturing excellence, YEX™ can be effortlessly integrated into your workflows, replacing FBS and offering a suite of advantages that elevate efficiency, drive cost-effectiveness, and uphold unwavering quality.

Contact the YEX Team to elevate your cell growth strategies and connect with our experts to discuss how YEX™ aligns with your unique needs!

Choose the category that applies to you:

Biosimilar
manufacturers 

Learn more

Originator biologic
manufacturers 

Learn more

By unlocking the full potential of specialized cell types, YEX fuels innovation across diverse biotechnological horizons.

Monoclonal antibody production

Regenerative medicine

Virus production

Drug discovery and screening

Clinical diagnostics

Recombinant protein production